vix.ing · top · new · best · stats · spec

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

2022/11/01 by Yu Fujiwara, Shumei Kato, Mary K Nesline +4 · 1 citation

paper · doi:10.1016/j.ctrv.2022.102461

Cited by